Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3)
    6.
    发明授权
    Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3) 失效
    骨骼肌和成骨细胞与神经营养因子-3(NT-3)的治疗方法

    公开(公告)号:US6080720A

    公开(公告)日:2000-06-27

    申请号:US505539

    申请日:1995-07-21

    CPC分类号: A61K38/185

    摘要: This invention relates to a composition for metabolic bone diseaese and/or bone fractures which comprises a pharmaceutically acceptable carrier and human neurotrophin-3 (NT-3).This invention also relates to a method for the treatment and/or prevention of metabolic bone diseaese or bone fractures which comprises administering to a patient in need of said treatment and/or prevention a medicament containing an effective amount of human neurotrophin-3 (NT-3).

    摘要翻译: 本发明涉及一种用于代谢性骨病和/或骨折的组合物,其包含药学上可接受的载体和人神经营养因子-3(NT-3)。 本发明还涉及用于治疗和/或预防代谢性骨病或骨折的方法,其包括向需要所述治疗和/或预防的患者施用含有有效量的人神经营养因子-3(NT- 3)。

    Calcitonin and method for the preparation and use thereof
    8.
    发明授权
    Calcitonin and method for the preparation and use thereof 失效
    降钙素及其制备方法及用途

    公开(公告)号:US5440012A

    公开(公告)日:1995-08-08

    申请号:US952735

    申请日:1992-11-30

    CPC分类号: C07K14/585 A61K38/00

    摘要: A calcitonin originated from the ultimobranchial gland of cartilaginous fishes and having a blood calcium-decreasing activity has the following amino acid sequence: H-Cys-Thr-Ser-Leu-Ser-Thr-Cys-Val-Val-Gly-Lys-Leu-Ser-Gln-Gln-Leu-His-Lys-Leu-Gln-Asn-Ile-Gln-Arg-Thr-Asp-Val-Gly-Ala-Ala-Thr-Pro-NH.sub.2, where the cysteine residues in the peptide may be linked together through a disulfide bond. The novel peptide exhibits an excellent blood calcium-decreasing activity and an excellent chondrocyte differentiation-promoting activity and is useful as a therapeutic agent for hypercalcemia, osteoporosis, Paget's disease, and the like.

    摘要翻译: PCT No.PCT / JP92 / 00706 Sec。 371日期:1992年11月30日 102(e)日期1992年11月30日PCT提交1992年5月29日PCT公布。 WO92 / 21700 PCT出版物 日期:1992年10月12日。降钙素源自软骨鱼的最终支气管,具有降血糖活性,具有以下氨基酸序列:H-Cys-Thr-Ser-Leu-Ser-Thr-Cys-Val- Val-Gly-Lys-Leu-Ser-Gln-Gln-Leu-His-Lys-Leu-Gln-Asn-Ile-Gln-Arg-Thr-Asp-Val-Gly-Ala-Ala-Thr-Pro-NH2, 其中肽中的半胱氨酸残基可以通过二硫键连接在一起。 该新型肽显示出优异的血液钙降低活性和优异的软骨细胞分化促进活性,可用作高钙血症,骨质疏松症,佩吉特氏病等的治疗剂。